+1 347 708 0418
HIV Vaccines market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global HIV Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Phase I
Phase II
Phase III
Segment by Application
Research Institute
Others
By Company
Argos Therapeutics
Bionor Pharma
Janssen Global Services
Genecure
Geovax
Paxvax
Inovio Pharmaceuticals
Glaxosmithkline
Sanofi
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.3 Market by Application
1.3.1 Global HIV Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Institute
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Vaccines Market Perspective (2017-2028)
2.2 HIV Vaccines Growth Trends by Region
2.2.1 HIV Vaccines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 HIV Vaccines Historic Market Size by Region (2017-2022)
2.2.3 HIV Vaccines Forecasted Market Size by Region (2023-2028)
2.3 HIV Vaccines Market Dynamics
2.3.1 HIV Vaccines Industry Trends
2.3.2 HIV Vaccines Market Drivers
2.3.3 HIV Vaccines Market Challenges
2.3.4 HIV Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Vaccines Players by Revenue
3.1.1 Global Top HIV Vaccines Players by Revenue (2017-2022)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2017-2022)
3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Vaccines Revenue
3.4 Global HIV Vaccines Market Concentration Ratio
3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2021
3.5 HIV Vaccines Key Players Head office and Area Served
3.6 Key Players HIV Vaccines Product Solution and Service
3.7 Date of Enter into HIV Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Vaccines Breakdown Data by Type
4.1 Global HIV Vaccines Historic Market Size by Type (2017-2022)
4.2 Global HIV Vaccines Forecasted Market Size by Type (2023-2028)
5 HIV Vaccines Breakdown Data by Application
5.1 Global HIV Vaccines Historic Market Size by Application (2017-2022)
5.2 Global HIV Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America HIV Vaccines Market Size (2017-2028)
6.2 North America HIV Vaccines Market Size by Type
6.2.1 North America HIV Vaccines Market Size by Type (2017-2022)
6.2.2 North America HIV Vaccines Market Size by Type (2023-2028)
6.2.3 North America HIV Vaccines Market Share by Type (2017-2028)
6.3 North America HIV Vaccines Market Size by Application
6.3.1 North America HIV Vaccines Market Size by Application (2017-2022)
6.3.2 North America HIV Vaccines Market Size by Application (2023-2028)
6.3.3 North America HIV Vaccines Market Share by Application (2017-2028)
6.4 North America HIV Vaccines Market Size by Country
6.4.1 North America HIV Vaccines Market Size by Country (2017-2022)
6.4.2 North America HIV Vaccines Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe HIV Vaccines Market Size (2017-2028)
7.2 Europe HIV Vaccines Market Size by Type
7.2.1 Europe HIV Vaccines Market Size by Type (2017-2022)
7.2.2 Europe HIV Vaccines Market Size by Type (2023-2028)
7.2.3 Europe HIV Vaccines Market Share by Type (2017-2028)
7.3 Europe HIV Vaccines Market Size by Application
7.3.1 Europe HIV Vaccines Market Size by Application (2017-2022)
7.3.2 Europe HIV Vaccines Market Size by Application (2023-2028)
7.3.3 Europe HIV Vaccines Market Share by Application (2017-2028)
7.4 Europe HIV Vaccines Market Size by Country
7.4.1 Europe HIV Vaccines Market Size by Country (2017-2022)
7.4.2 Europe HIV Vaccines Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Vaccines Market Size (2017-2028)
8.2 Asia-Pacific HIV Vaccines Market Size by Type
8.2.1 Asia-Pacific HIV Vaccines Market Size by Type (2017-2022)
8.2.2 Asia-Pacific HIV Vaccines Market Size by Type (2023-2028)
8.2.3 Asia-Pacific HIV Vaccines Market Share by Type (2017-2028)
8.3 Asia-Pacific HIV Vaccines Market Size by Application
8.3.1 Asia-Pacific HIV Vaccines Market Size by Application (2017-2022)
8.3.2 Asia-Pacific HIV Vaccines Market Size by Application (2023-2028)
8.3.3 Asia-Pacific HIV Vaccines Market Share by Application (2017-2028)
8.4 Asia-Pacific HIV Vaccines Market Size by Region
8.4.1 Asia-Pacific HIV Vaccines Market Size by Region (2017-2022)
8.4.2 Asia-Pacific HIV Vaccines Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HIV Vaccines Market Size (2017-2028)
9.2 Latin America HIV Vaccines Market Size by Type
9.2.1 Latin America HIV Vaccines Market Size by Type (2017-2022)
9.2.2 Latin America HIV Vaccines Market Size by Type (2023-2028)
9.2.3 Latin America HIV Vaccines Market Share by Type (2017-2028)
9.3 Latin America HIV Vaccines Market Size by Application
9.3.1 Latin America HIV Vaccines Market Size by Application (2017-2022)
9.3.2 Latin America HIV Vaccines Market Size by Application (2023-2028)
9.3.3 Latin America HIV Vaccines Market Share by Application (2017-2028)
9.4 Latin America HIV Vaccines Market Size by Country
9.4.1 Latin America HIV Vaccines Market Size by Country (2017-2022)
9.4.2 Latin America HIV Vaccines Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Vaccines Market Size (2017-2028)
10.2 Middle East & Africa HIV Vaccines Market Size by Type
10.2.1 Middle East & Africa HIV Vaccines Market Size by Type (2017-2022)
10.2.2 Middle East & Africa HIV Vaccines Market Size by Type (2023-2028)
10.2.3 Middle East & Africa HIV Vaccines Market Share by Type (2017-2028)
10.3 Middle East & Africa HIV Vaccines Market Size by Application
10.3.1 Middle East & Africa HIV Vaccines Market Size by Application (2017-2022)
10.3.2 Middle East & Africa HIV Vaccines Market Size by Application (2023-2028)
10.3.3 Middle East & Africa HIV Vaccines Market Share by Application (2017-2028)
10.4 Middle East & Africa HIV Vaccines Market Size by Country
10.4.1 Middle East & Africa HIV Vaccines Market Size by Country (2017-2022)
10.4.2 Middle East & Africa HIV Vaccines Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Details
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics HIV Vaccines Introduction
11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2017-2022)
11.1.5 Argos Therapeutics Recent Developments
11.2 Bionor Pharma
11.2.1 Bionor Pharma Company Details
11.2.2 Bionor Pharma Business Overview
11.2.3 Bionor Pharma HIV Vaccines Introduction
11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2017-2022)
11.2.5 Bionor Pharma Recent Developments
11.3 Janssen Global Services
11.3.1 Janssen Global Services Company Details
11.3.2 Janssen Global Services Business Overview
11.3.3 Janssen Global Services HIV Vaccines Introduction
11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2017-2022)
11.3.5 Janssen Global Services Recent Developments
11.4 Genecure
11.4.1 Genecure Company Details
11.4.2 Genecure Business Overview
11.4.3 Genecure HIV Vaccines Introduction
11.4.4 Genecure Revenue in HIV Vaccines Business (2017-2022)
11.4.5 Genecure Recent Developments
11.5 Geovax
11.5.1 Geovax Company Details
11.5.2 Geovax Business Overview
11.5.3 Geovax HIV Vaccines Introduction
11.5.4 Geovax Revenue in HIV Vaccines Business (2017-2022)
11.5.5 Geovax Recent Developments
11.6 Paxvax
11.6.1 Paxvax Company Details
11.6.2 Paxvax Business Overview
11.6.3 Paxvax HIV Vaccines Introduction
11.6.4 Paxvax Revenue in HIV Vaccines Business (2017-2022)
11.6.5 Paxvax Recent Developments
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Details
11.7.2 Inovio Pharmaceuticals Business Overview
11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2017-2022)
11.7.5 Inovio Pharmaceuticals Recent Developments
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Company Details
11.8.2 Glaxosmithkline Business Overview
11.8.3 Glaxosmithkline HIV Vaccines Introduction
11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2017-2022)
11.8.5 Glaxosmithkline Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi HIV Vaccines Introduction
11.9.4 Sanofi Revenue in HIV Vaccines Business (2017-2022)
11.9.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Global HIV Vaccines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global HIV Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global HIV Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global HIV Vaccines Market Share by Region (2017-2022)
Table 9. Global HIV Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global HIV Vaccines Market Share by Region (2023-2028)
Table 11. HIV Vaccines Market Trends
Table 12. HIV Vaccines Market Drivers
Table 13. HIV Vaccines Market Challenges
Table 14. HIV Vaccines Market Restraints
Table 15. Global HIV Vaccines Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global HIV Vaccines Revenue Share by Players (2017-2022)
Table 17. Global Top HIV Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Vaccines as of 2021)
Table 18. Ranking of Global Top HIV Vaccines Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by HIV Vaccines Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HIV Vaccines Product Solution and Service
Table 22. Date of Enter into HIV Vaccines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global HIV Vaccines Revenue Market Share by Type (2017-2022)
Table 26. Global HIV Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global HIV Vaccines Revenue Market Share by Type (2023-2028)
Table 28. Global HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global HIV Vaccines Revenue Share by Application (2017-2022)
Table 30. Global HIV Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global HIV Vaccines Revenue Share by Application (2023-2028)
Table 32. North America HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America HIV Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America HIV Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America HIV Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America HIV Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe HIV Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe HIV Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe HIV Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe HIV Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific HIV Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific HIV Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific HIV Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific HIV Vaccines Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America HIV Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America HIV Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America HIV Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America HIV Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa HIV Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa HIV Vaccines Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa HIV Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa HIV Vaccines Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa HIV Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa HIV Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 62. Argos Therapeutics Company Details
Table 63. Argos Therapeutics Business Overview
Table 64. Argos Therapeutics HIV Vaccines Product
Table 65. Argos Therapeutics Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 66. Argos Therapeutics Recent Developments
Table 67. Bionor Pharma Company Details
Table 68. Bionor Pharma Business Overview
Table 69. Bionor Pharma HIV Vaccines Product
Table 70. Bionor Pharma Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 71. Bionor Pharma Recent Developments
Table 72. Janssen Global Services Company Details
Table 73. Janssen Global Services Business Overview
Table 74. Janssen Global Services HIV Vaccines Product
Table 75. Janssen Global Services Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 76. Janssen Global Services Recent Developments
Table 77. Genecure Company Details
Table 78. Genecure Business Overview
Table 79. Genecure HIV Vaccines Product
Table 80. Genecure Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 81. Genecure Recent Developments
Table 82. Geovax Company Details
Table 83. Geovax Business Overview
Table 84. Geovax HIV Vaccines Product
Table 85. Geovax Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 86. Geovax Recent Developments
Table 87. Paxvax Company Details
Table 88. Paxvax Business Overview
Table 89. Paxvax HIV Vaccines Product
Table 90. Paxvax Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 91. Paxvax Recent Developments
Table 92. Inovio Pharmaceuticals Company Details
Table 93. Inovio Pharmaceuticals Business Overview
Table 94. Inovio Pharmaceuticals HIV Vaccines Product
Table 95. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 96. Inovio Pharmaceuticals Recent Developments
Table 97. Glaxosmithkline Company Details
Table 98. Glaxosmithkline Business Overview
Table 99. Glaxosmithkline HIV Vaccines Product
Table 100. Glaxosmithkline Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 101. Glaxosmithkline Recent Developments
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi HIV Vaccines Product
Table 105. Sanofi Revenue in HIV Vaccines Business (2017-2022) & (US$ Million)
Table 106. Sanofi Recent Developments
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Vaccines Market Share by Type: 2021 VS 2028
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Global HIV Vaccines Market Share by Application: 2021 VS 2028
Figure 6. Research Institute Case Studies
Figure 7. Others Case Studies
Figure 8. HIV Vaccines Report Years Considered
Figure 9. Global HIV Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global HIV Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global HIV Vaccines Market Share by Region: 2021 VS 2028
Figure 12. Global HIV Vaccines Market Share by Players in 2021
Figure 13. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Vaccines as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2021
Figure 15. North America HIV Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America HIV Vaccines Market Size Market Share by Type (2017-2028)
Figure 17. North America HIV Vaccines Market Size Market Share by Application (2017-2028)
Figure 18. North America HIV Vaccines Market Size Share by Country (2017-2028)
Figure 19. United States HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe HIV Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe HIV Vaccines Market Size Market Share by Type (2017-2028)
Figure 23. Europe HIV Vaccines Market Size Market Share by Application (2017-2028)
Figure 24. Europe HIV Vaccines Market Size Share by Country (2017-2028)
Figure 25. Germany HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific HIV Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific HIV Vaccines Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific HIV Vaccines Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific HIV Vaccines Market Size Share by Region (2017-2028)
Figure 35. China HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America HIV Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America HIV Vaccines Market Size Market Share by Type (2017-2028)
Figure 43. Latin America HIV Vaccines Market Size Market Share by Application (2017-2028)
Figure 44. Latin America HIV Vaccines Market Size Share by Country (2017-2028)
Figure 45. Mexico HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa HIV Vaccines Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa HIV Vaccines Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa HIV Vaccines Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa HIV Vaccines Market Size Share by Country (2017-2028)
Figure 51. Turkey HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE HIV Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Argos Therapeutics Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 55. Bionor Pharma Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 56. Janssen Global Services Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 57. Genecure Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 58. Geovax Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 59. Paxvax Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 60. Inovio Pharmaceuticals Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 61. Glaxosmithkline Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in HIV Vaccines Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Buy
